198 related articles for article (PubMed ID: 2901288)
1. Clonal genomic alterations in glioma malignancy stages.
James CD; Carlbom E; Dumanski JP; Hansen M; Nordenskjold M; Collins VP; Cavenee WK
Cancer Res; 1988 Oct; 48(19):5546-51. PubMed ID: 2901288
[TBL] [Abstract][Full Text] [Related]
2. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
Frankel RH; Bayona W; Koslow M; Newcomb EW
Cancer Res; 1992 Mar; 52(6):1427-33. PubMed ID: 1347252
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 9 deletion mapping reveals interferon alpha and interferon beta-1 gene deletions in human glial tumors.
James CD; He J; Carlbom E; Nordenskjold M; Cavenee WK; Collins VP
Cancer Res; 1991 Mar; 51(6):1684-8. PubMed ID: 1998958
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the TP53 gene in human gliomas.
Rasheed BK; McLendon RE; Herndon JE; Friedman HS; Friedman AH; Bigner DD; Bigner SH
Cancer Res; 1994 Mar; 54(5):1324-30. PubMed ID: 8118823
[TBL] [Abstract][Full Text] [Related]
5. Tumor progression stage: specific losses of heterozygosity.
Cavenee WK
Princess Takamatsu Symp; 1989; 20():33-42. PubMed ID: 2488236
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.
Rempel SA; Schwechheimer K; Davis RL; Cavenee WK; Rosenblum ML
Cancer Res; 1993 May; 53(10 Suppl):2386-92. PubMed ID: 8485725
[TBL] [Abstract][Full Text] [Related]
7. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
Jin W; Xu X; Yang T; Hua Z
Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043
[TBL] [Abstract][Full Text] [Related]
8. Frequency of IFN beta 1 gene loss in 47 primary human gliomas.
Sugawa N; Ekstrand AJ; Ueda S; Collins VP
Noshuyo Byori; 1993; 10(2):161-3. PubMed ID: 8106098
[TBL] [Abstract][Full Text] [Related]
9. Allelotype of human malignant astrocytoma.
Fults D; Pedone CA; Thomas GA; White R
Cancer Res; 1990 Sep; 50(18):5784-9. PubMed ID: 1975510
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma.
Fults D; Tippets RH; Thomas GA; Nakamura Y; White R
Cancer Res; 1989 Dec; 49(23):6572-7. PubMed ID: 2573417
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.
Rasheed BK; McLendon RE; Friedman HS; Friedman AH; Fuchs HE; Bigner DD; Bigner SH
Oncogene; 1995 Jun; 10(11):2243-6. PubMed ID: 7784070
[TBL] [Abstract][Full Text] [Related]
12. Fine mapping of a region of common deletion on chromosome arm 10p in human glioma.
Voesten AM; Bijleveld EH; Westerveld A; Hulsebos TJ
Genes Chromosomes Cancer; 1997 Oct; 20(2):167-72. PubMed ID: 9331567
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines.
Roversi G; Pfundt R; Moroni RF; Magnani I; van Reijmersdal S; Pollo B; Straatman H; Larizza L; Schoenmakers EF
Oncogene; 2006 Mar; 25(10):1571-83. PubMed ID: 16247447
[TBL] [Abstract][Full Text] [Related]
14. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
15. Gliomas.
Collins VP
Cancer Surv; 1998; 32():37-51. PubMed ID: 10489622
[TBL] [Abstract][Full Text] [Related]
16. Phenotype versus genotype in gliomas displaying inter- or intratumoral histological heterogeneity.
Walker C; du Plessis DG; Joyce KA; Machell Y; Thomson-Hehir J; Al Haddad SA; Broome JC; Warnke PC
Clin Cancer Res; 2003 Oct; 9(13):4841-51. PubMed ID: 14581356
[TBL] [Abstract][Full Text] [Related]
17. Angiocentric glioma: report of clinico-pathologic and genetic findings in 8 cases.
Preusser M; Hoischen A; Novak K; Czech T; Prayer D; Hainfellner JA; Baumgartner C; Woermann FG; Tuxhorn IE; Pannek HW; Bergmann M; Radlwimmer B; Villagrán R; Weber RG; Hans VH
Am J Surg Pathol; 2007 Nov; 31(11):1709-18. PubMed ID: 18059228
[TBL] [Abstract][Full Text] [Related]
18. Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas.
Hermanson M; Funa K; Koopmann J; Maintz D; Waha A; Westermark B; Heldin CH; Wiestler OD; Louis DN; von Deimling A; Nistér M
Cancer Res; 1996 Jan; 56(1):164-71. PubMed ID: 8548759
[TBL] [Abstract][Full Text] [Related]
19. The putative tumor suppressor gene FHIT at 3p14.2 is rarely affected by loss of heterozygosity in primary human brain tumors.
Frank S; Müller J; Plaschke J; Hahn M; Hampl J; Hampl M; Pistorius S; Schackert G; Schackert HK
Cancer Res; 1997 Jul; 57(13):2638-41. PubMed ID: 9205070
[TBL] [Abstract][Full Text] [Related]
20. Cytogenical analysis of brain tumors by FISH (fluorescence in situ hybridization) and FCM (flow cytometry).
Kasai H; Kawamoto K
Noshuyo Byori; 1995 Mar; 12(1):75-82. PubMed ID: 7795734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
